Lp(a) and OxPL are implicated in driving valve calcification and progression of aortic stenosis, providing a mechanistic rationale for future clinical trials targeting these pathways.
Lp(a) and OxPL may promote aortic stenosis progression; hypothesis-generating for targeted therapies pending randomized trials.
In patients with AS, Lp(a) and OxPL drive valve calcification and disease progression. These findings suggest lowering Lp(a) or inactivating OxPL may slow AS progression and provide a rationale for clinical trials to test this hypothesis.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: